Sunday, June 23, 2013
Judge Approves $35 Million Flonase Antitrust Settlement
Days after approving a $150 million class action settlement between direct purchasers of nasal spray Flonase and manufacturer GlaxoSmithKline, a federal judge has approved a $35 million settlement between GSK and the indirect purchasers of the drug.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment